<DOC>
	<DOCNO>NCT01910766</DOCNO>
	<brief_summary>Objective study evaluate effect combination oral Coenzyme Q10 ( CoQ10 ) , clomiphene citrate ( CC ) ovulation induction CC-resistant polycystic ovary syndrome ( PCOS ) .In prospective control randomized trial perform university hospital private practice set . One hundred ten infertile woman PCOS resistant CC randomize either combine CC/CoQ10 ( 51 patient , 82 cycle ) CC 150 mg/day alone ( 50 patient , 71 cycle ) ovulation induction patient CC-resistant PCOS . Main outcome measure : Number follicle , serum E2 , serum P , endometrial thickness , pregnancy rate ( PR ) miscarriage rate .</brief_summary>
	<brief_title>Coenzyme Q10 Clomiphene Citrate ( CC ) Ovulation Induction Polycystic Ovary Syndrome</brief_title>
	<detailed_description>No detail</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Diagnosis PCOS base revised 2003 consensus diagnostic criterion longterm health risk relate PCOS ( 2003 ) . All woman previously treat 100 mg CC daily 5 day per cycle , two three cycle persistent anovulation ovulate thin endometrium &lt; 5 mm time hCG administration patient hyperprolactinaemia , hypercorticism thyroid dysfunction . patient receive medication cholesterol lower drug , statin , betablockers , tricyclic antidepressant</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>pcos</keyword>
	<keyword>coenzymeQ10</keyword>
	<keyword>clomiphene citrate</keyword>
</DOC>